Target intelligence / Profile preview

UL16-Binding Protein Family Ligand (ULBP1–6) (ULBP1-6)

Target
ULBP1-6
Molecular classification
MHC class I-related, Glycoprotein, Receptor Ligand
01

Overview

The UL16-binding protein (ULBP) family, comprising ULBP1 through ULBP6, represents a group of cell surface glycoproteins that are structurally related to MHC class I molecules and serve as ligands for the activating immune receptor NKG2D, which is expressed on natural killer (NK) cells and certain T-cell subsets. ULBPs are stress-induced ligands, upregulated in response to cellular stress such as infection or transformation, triggering activation signals in NK cells or cytotoxic T lymphocytes, leading to immune effector functions including cytotoxicity against target cells. High expression of certain ULBPs has been observed in various hematologic malignancies and solid tumors making them attractive targets for immunotherapeutic strategies such as CAR-T therapies targeting NKG2D ligands. HCMV can evade this mechanism through the protein UL16.

Other names
ULBP1ULBP2ULBP3ULBP4ULBP5ULBP6RAET1I (ULBP1)RAET1H (ULBP2)RAET1N (ULBP3)NKG2DL1 (ULBP1)
02

Mechanism of action

ULBPs engage NKG2D receptors → activate DAP10 adaptor → trigger downstream signaling cascades: JAK/STAT, ERK/MAPK, PI3K/Akt. This leads to enhanced NK cell-mediated lysis, increased cytokine secretion (especially IFN-gamma when synergizing with IL‑12), and overcoming inhibitory signals from self-MHC recognition by NK cells.

03

Biological functions

Immune responseNK cell activationT cell activationCytotoxicityCytokine productionLigand for activating receptor NKG2D
04

Disease associations

CancerViral infectionNasopharyngeal carcinomaAcute myeloid leukemia
05

Safety considerations

Potential for off-target effects due to widespread NKG2D expressionImmune-related adverse events
06

Biomarkers

ULBP expression levels in tumors

Beyond the preview

Go deeper on UL16-Binding Protein Family Ligand (ULBP1–6) (ULBP1-6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UL16-Binding Protein Family Ligand (ULBP1–6) (ULBP1-6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call